CT2 Program Lecture Series
CT2 includes 2 lecture series:
- Principles of Cancer Drug Therapeutics Development: This required lecture series consists of 12 weekly lectures delivered by CT2 and UCSD faculty members during the fall quarter. These lectures focus on the necessary sequential steps in drug development.
- Topics in Cancer Drug Development: This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal of this lecture series is to expose trainees to experts with a substantial track record dealing with the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.
The combined schedule is available here: